Financhill
Sell
41

CTMX Quote, Financials, Valuation and Earnings

Last price:
$1.07
Seasonality move :
-0.08%
Day range:
$1.06 - $1.15
52-week range:
$0.83 - $5.85
Dividend yield:
0%
P/E ratio:
6.65x
P/S ratio:
0.75x
P/B ratio:
--
Volume:
1.2M
Avg. volume:
1.5M
1-year change:
-23.65%
Market cap:
$88.4M
Revenue:
$101.2M
EPS (TTM):
$0.17

Earnings Data

Next earnings date for CTMX
Mar 11
2025
Most recent earnings per share
$0.07
Beat by $0.25
(Nov 7/2024)
Consensus Estimate
-$0.18
(Nov 7/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CTMX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/11/2025 Q4 $13.5M -- -- -$0.13 --
11/07/2024 Q3 $17.1M $33.4M $0.07 -$0.18 $0.25
08/08/2024 Q2 $20M $25.1M -$0.08 -$0.05 -$0.03
05/08/2024 Q1 $21.7M $41.5M $0.17 -$0.06 $0.23
03/11/2024 Q4 $21.2M $26.6M $0.01 -$0.03 $0.04
11/07/2023 Q3 -- -- $0.04 -$0.21 $0.25
08/08/2023 Q2 -- -- -$0.02 -$0.20 $0.18
05/09/2023 Q1 -- -- -$0.05 -$0.11 $0.06
03/27/2023 Q4 -- -- -$0.13 -$0.24 $0.11
11/08/2022 Q3 -- -- -$0.35 -$0.33 -$0.02
08/04/2022 Q2 -- -- -$0.37 -$0.40 $0.03
05/05/2022 Q1 -- -- -$0.37 -$0.36 -$0.01
03/01/2022 Q4 -- -- -$0.40 -$0.35 -$0.05
11/04/2021 Q3 -- -- -$0.35 -$0.30 -$0.05
08/05/2021 Q2 -- -- -$0.30 -$0.31 $0.01
05/07/2021 Q1 -- -- -$0.26 -$0.35 $0.09
02/24/2021 Q4 -- -- -$0.31 -$0.51 $0.20
11/05/2020 Q3 -- -- -$0.32 -$0.49 $0.17
08/06/2020 Q2 -- -- -$0.34 $0.03 -$0.37
05/07/2020 Q1 -- -- $0.26 -$0.51 $0.77
02/27/2020 Q4 -- -- -$0.79 -$0.51 -$0.28
11/07/2019 Q3 -- -- -$0.52 -$0.46 -$0.06
08/07/2019 Q2 -- -- -$0.64 -$0.59 -$0.05
05/09/2019 Q1 -- -- -$0.31 -$0.52 $0.21
02/27/2019 Q4 -- -- -$0.74 -$0.49 -$0.25
11/06/2018 Q3 -- -- -$0.53 -- --
08/08/2018 Q2 -- -- -$0.35 -- --
05/09/2018 Q1 -- -- -$0.40 -- --
03/07/2018 Q4 -- -- $0.03 -- --
10/26/2017 Q3 -- -- -$0.28 -- --
08/07/2017 Q2 -- -- -$0.69 -- --
05/05/2017 Q1 -- -- -$0.23 -- --
03/01/2017 Q4 -- -- -$0.39 -- --
10/27/2016 Q3 -- -- -$0.40 -- --
08/03/2016 Q2 -- -- -$0.39 -- --
03/31/2016 Q1 -- -- -$0.44 -- --
12/31/2015 Q4 -- -- -$0.33 -- --
09/30/2015 Q3 -- -- -$0.42 -- --
06/30/2015 Q2 -- -- -$0.22 -- --
03/31/2015 Q1 -- -- -$0.22 -- --
12/31/2014 Q4 -- -- -$0.17 -- --

CytomX Therapeutics Earnings Questions

  • How Much did CytomX Therapeutics Generate in Revenue Last Quarter?

    CytomX Therapeutics reported $33.4M worth of top line sales in its most recent quarter.

  • Did CytomX Therapeutics Beat Earnings Last Quarter?

    CytomX Therapeutics announced earnings per share of $0.07 which represents a beat of analyst forecast a -$0.18 per share.

  • Is CytomX Therapeutics Profitable?

    CytomX Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for CytomX Therapeutics EPS Next Year?

    CytomX Therapeutics's earnings are forecast to decrease from -$0.01 per share to -$0.03 per share next year representing a decrease of -1247.8%.

  • When is CytomX Therapeutics's Earnings Date?

    CytomX Therapeutics's next earnings date is March 11, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Uber Stock a Buy on the Dip?
Is Uber Stock a Buy on the Dip?

Shares of Uber Technologies (NYSE:UBER) have been fading fast in…

Is AMD Stock an All-Time Buy?
Is AMD Stock an All-Time Buy?

Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 43x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
57
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
64
ARQQ alert for Dec 27

Arqit Quantum [ARQQ] is down 3.22% over the past day.

Buy
64
QMCO alert for Dec 27

Quantum [QMCO] is up 4.72% over the past day.

Buy
65
ALGS alert for Dec 27

Aligos Therapeutics [ALGS] is down 4.82% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock